Business Description
Halozyme Therapeutics is a biopharmaceutical company built around a patented enzyme technology that makes it easier to deliver drugs under the skin rather than through a vein, improving convenience for patients and expanding options for drug makers. Founded in 1998 and based in San Diego, the company markets its own products while licensing its core technology to many of the world's largest pharmaceutical companies, including Pfizer, AbbVie, Eli Lilly, and Bristol Myers Squibb. This licensing model has enabled a broad portfolio of treatments spanning cancer, multiple sclerosis, immune disorders, and other serious conditions across markets in the United States, Europe, Japan, and beyond.
